About us
BUSINESS STRATEGY
CEL-SCI Corporation (NYSE MKT: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
Read more...V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.
V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.
Mission & Values
Hired profesors, doctors
and other specialist in our
hospital
OUR STAFF
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla mauris dolor.
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.
Prof. Jepherson
Shulter
Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.
Prof. Marcus
Filtz
Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.
Prof. Jepherson
Shulter
Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.
Prof. Marcus
Filtz
Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.